Buhr Hj

Immunological Monitoring of Cancer Patients During a Phase I/II Clinical Trial of Natural Interleukin-2

H. Lenz, G. Pawelec, G. Ehninger, 1990 .

Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.

D. Birnbaum, L. Kanz, C. Hannum, 1996, Leukemia.

Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia.

Ø. Bruserud, G. Pawelec, O. Brustugun, 1995, Leukemia.

Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow.

A. Saalmüller, M. Letarte, H. Bühring, 1991, Leukemia.

Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia

H. Rammensee, H. Salih, K. Schilbach, 2012, Leukemia.